Editor's Favorite: Nakanishi N and colleagues article "Impact of Patient Age and Histological Type on Radioactive Iodine Avidity of Recurrent Lesions of Differentiated Thyroid Carcinoma"​ retrospectively correlates the impact of age and histological type on the RAI avidity of recurrent lesions of DTC in 258 patients; 189 with classic papillary thyroid carcinoma [cPTC], 8 with follicular variant of papillary thyroid carcinoma, and 61 with follicular thyroid carcinoma.

They demonstrated a significant inverse correlation with age (<55 years, 36.2%; ≥55 years, 3%; p < 0.001) and RAI-avid cPTC lung metastases. Contrarily, RAI avidity for follicular thyroid carcinoma metastases was not influenced by age.  Authors argue for earlier consideration of molecular-targeted drugs in patients with older than 55 with classic papillary thyroid carcinoma, especially if there is no visual evidence for radioiodine avid metastases.​

Current Issue

Combined [18F]-Fluoroethylcholine PET/CT and 99mTc–Macroaggregated Albumin SPECT/CT Predict Survival in Patients With Intermediate-Stage Hepatocellular Carcinoma

Hartenbach, Markus; Weber, Stefan; Pilz, Magdalena; More

Clinical Nuclear Medicine. 43(7):477-481, July 2018.

Prediction of Normal Organ Absorbed Doses for [177Lu]Lu-PSMA-617 Using [44Sc]Sc-PSMA-617 Pharmacokinetics in Patients With Metastatic Castration Resistant Prostate Carcinoma

Khawar, Ambreen; Eppard, Elisabeth; Sinnes, Jean Phlippe; More

Clinical Nuclear Medicine. 43(7):486-491, July 2018.